- $15.44m
- $15.54m
- $0.14m
Annual income statement for Vemanti, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0.327 | 0.162 | 0.148 | 0.139 |
| Cost of Revenue | ||||
| Gross Profit | 0.263 | 0.126 | 0.126 | 0.116 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Total Operating Expenses | 0.57 | 0.247 | 1.76 | 1.18 |
| Operating Profit | -0.243 | -0.084 | -1.62 | -1.04 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -0.226 | -0.075 | -1.62 | -1.04 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -0.226 | -0.077 | -1.63 | -1.04 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.226 | -0.077 | -1.63 | -1.04 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Dilution Adjustment | ||||
| Diluted Net Income | -0.226 | -0.077 | -1.63 | -1.04 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.003 | -0.001 | -0.023 | -0.015 |
| Dividends per Share |